Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
Part of paid clinical trials in Ann Arbor, Michigan.
- Sponsor
- University of Michigan
- Study ID
- NCT00748254
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Laser Based Photoacoustic Tomography, MRI, Ultrasound — PROCEDUREHealthy subjects will have scans on finger joints with any of the scanning methods described above.
- laser based photoacoustic tomography, MRI, ultrasound — PROCEDURESubjects with arthritis will have scans on finger joints with any of the scanning methods described above.
Study Details
The purpose of this feasibility study is to determine if a new emerging technology called photoacoustic tomography (PAT) can be adapted for use in humans for the detection of chronic rheumatoid arthritis.
Key Dates
- Start date
- Dec 1, 2011
- Status verified
- Jan 2026
- Primary completion
- Jan 31, 2027
- Completion
- Jan 31, 2027
Study Design
- Enrollment
- 113 participants (estimated)
Arms
- Arm: Rheumatoid ArthritisPatients who have active disease affecting the joints in the hand will have Laser Based Photoacoustic Tomography (PAT), MRI, Ultrasound
- Arm: Normal controlsHealthy volunteers who do not have arthritis will also have Laser Based Photoacoustic Tomography (PAT), MRI, Ultrasound on the joints of their hand
Primary Outcome Measure
Photoacoustic Imaging [ Time Frame: 10 weeks ]
Central Contacts
- Safa Mohamed734 615-1646
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Universtity of Michigan Health System | Ann Arbor | Michigan | 48109 | Xueding Wang, PHD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Ann Arbor, MI
By condition
By research site
Related Studies
- A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)PHASE2 · Recruiting · Merck Sharp & Dohme LLC · Glendale, Arizona
- IMPACT - AndHealth Autoimmune Research RegistryRecruiting · AndHealth · Columbus, Ohio
- R-2487 in Patients With Rheumatoid ArthritisPHASE1 · Recruiting · Rise Therapeutics LLC · San Diego, California
- Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid ArthritisNot Yet Recruiting · Tufts Medical Center · Boston, Massachusetts